There are currently no shortages of GLP1s that we are aware of, therefore there is no longer a restriction on starting new patients on GLP1s if they meet the criteria for 3rd line treatment of Type 2 Diabetes Mellitus. If semaglutide (orally as Rybelsus or via injection as Ozempic), dulaglutide (Trulicity) or tirzepatide (Mounjaro) are indicated for a patient then they should be available.\u00a0<\/p>\n\n\n\n
Please follow the Diabetes MCN prescribing guidelines and East Region Formulary link to the Type 2 Diabetes Mellitus guidelines below:<\/p>\n\n\n\n
Diabetes MCN Anti-Diabetic Therapy Guidelines for Type 2 Diabetes<\/a><\/p>\n\n\n\n Formulary | East Region Formulary<\/a><\/p>\n\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" There are currently no shortages of GLP1s that we are aware of, therefore there is no longer a restriction on starting new patients on GLP1s if they meet the criteria for 3rd line treatment of Type 2 Diabetes Mellitus. If semaglutide (orally as Rybelsus or via injection as Ozempic), dulaglutide (Trulicity) or tirzepatide (Mounjaro) are<\/p>\n","protected":false},"author":290,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"class_list":["post-1510","post","type-post","status-publish","format-standard","hentry","category-prescribing"],"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"nataliemartin","author_link":"https:\/\/services.nhslothian.scot\/diabetesservice\/author\/nataliemartin\/"},"rttpg_comment":0,"rttpg_category":"Prescribing Information<\/a>","rttpg_excerpt":"There are currently no shortages of GLP1s that we are aware of, therefore there is no longer a restriction on starting new patients on GLP1s if they meet the criteria for 3rd line treatment of Type 2 Diabetes Mellitus. If semaglutide (orally as Rybelsus or via injection as Ozempic), dulaglutide (Trulicity) or tirzepatide (Mounjaro) are","_links":{"self":[{"href":"https:\/\/services.nhslothian.scot\/diabetesservice\/wp-json\/wp\/v2\/posts\/1510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/services.nhslothian.scot\/diabetesservice\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/services.nhslothian.scot\/diabetesservice\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/services.nhslothian.scot\/diabetesservice\/wp-json\/wp\/v2\/users\/290"}],"replies":[{"embeddable":true,"href":"https:\/\/services.nhslothian.scot\/diabetesservice\/wp-json\/wp\/v2\/comments?post=1510"}],"version-history":[{"count":3,"href":"https:\/\/services.nhslothian.scot\/diabetesservice\/wp-json\/wp\/v2\/posts\/1510\/revisions"}],"predecessor-version":[{"id":1517,"href":"https:\/\/services.nhslothian.scot\/diabetesservice\/wp-json\/wp\/v2\/posts\/1510\/revisions\/1517"}],"wp:attachment":[{"href":"https:\/\/services.nhslothian.scot\/diabetesservice\/wp-json\/wp\/v2\/media?parent=1510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/services.nhslothian.scot\/diabetesservice\/wp-json\/wp\/v2\/categories?post=1510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}